Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition?

Medical hypotheses - 1 Feb 2012

Diz P, Limeres J, Fedele S, Seoane J, Diniz M, Feijoo J F

Abstract excerpt

Since the introduction of bisphosphonates to treat diseases that affect bone remodelling, there has been an increasing number of cases of bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ). Epidemiological data regarding BRONJ vary widely between studies, and a number of potential methodological biases have been detected. In some small preliminary studies, single nucleotide polymorphisms associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to Bone Density Conservation Agents
Share to Bone Remodeling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diphosphonates

Share to Geography

Share to Global Health

Share to Risk Factors

Source

Identifiers

PMID: 22136947
DOI: 10.1016/j.mehy.2011.11.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition?PMID 22136947Read ↗

Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series.Semantic proximity Read ↗

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.Semantic proximity Read ↗

Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the JawSemantic proximity Read ↗

New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw.Semantic proximity Read ↗

Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study.Semantic proximity Read ↗

Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw.Semantic proximity Read ↗

Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.Semantic proximity Read ↗

Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.Semantic proximity Read ↗

Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.Semantic proximity Read ↗

Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3.Semantic proximity Read ↗

Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives.Semantic proximity Read ↗

Denosumab-Related Osteonecrosis of the Jaw: a five year monocentric retrospective study of Ancona General HospitalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.